Literature DB >> 31629226

Runaway Kaposi Sarcoma-associated herpesvirus replication correlates with systemic IL-10 levels.

Carolina Caro-Vegas1, Subhashini Sellers2, Kurtis M Host1, Jedediah Seltzer1, Justin Landis1, William A Fischer2, Blossom Damania1, Dirk P Dittmer3.   

Abstract

KSHV-associated inflammatory cytokine syndrome (KICS) is caused by Kaposi's sarcoma-associated herpesvirus (KSHV). KICS is associated with high-level, systemic replication of KSHV. This study characterized the clinical and virologic features of a KICS patient over time. Additionally, it compared the cytokine profiles of the KICS case to Kaposi's sarcoma (KS) (n = 11) and non-KS (n = 6) cases. This KICS case presented with elevated levels of KSHV and IL-10, as expected. Surprisingly, this case did not have elevated levels of IL-6 or human immunodeficiency virus 1 (HIV-1). Nevertheless, treatment with anti-IL6 receptor antibody (tocilizumab) reduced KSHV viral load and IL-10. The KSHV genome sequence showed no significant changes over time, except in ORF24. Phylogenetic analysis established this isolate as belonging to KSHV clade A and closely related to other US isolates. These findings suggest IL-10 as potential biomarker and therapy target for KICS.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Castleman's disease; Herpesvirus; IRIS; KICS; KSHV; Kaposi's sarcoma; Tocilizumab

Mesh:

Substances:

Year:  2019        PMID: 31629226      PMCID: PMC6908428          DOI: 10.1016/j.virol.2019.10.002

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  25 in total

1.  Sequence analysis of Kaposi sarcoma-associated herpesvirus (KSHV) microRNAs in patients with multicentric Castleman disease and KSHV-associated inflammatory cytokine syndrome.

Authors:  Alex Ray; Vickie Marshall; Thomas Uldrick; Robert Leighty; Nazzarena Labo; Kathy Wyvill; Karen Aleman; Mark N Polizzotto; Richard F Little; Robert Yarchoan; Denise Whitby
Journal:  J Infect Dis       Date:  2012-03-23       Impact factor: 5.226

2.  Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men--New York City and California.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1981-07-03       Impact factor: 17.586

3.  Clinical and pathological characteristics of HIV- and HHV-8-negative Castleman disease.

Authors:  Li Yu; Meifeng Tu; Jorge Cortes; Zijun Y Xu-Monette; Roberto N Miranda; Jun Zhang; Robert Z Orlowski; Sattva Neelapu; Prajwal C Boddu; Mary A Akosile; Thomas S Uldrick; Robert Yarchoan; L Jeffrey Medeiros; Yong Li; David C Fajgenbaum; Ken H Young
Journal:  Blood       Date:  2017-01-18       Impact factor: 22.113

4.  Kaposi's sarcoma-associated herpesvirus bacterial artificial chromosome contains a duplication of a long unique-region fragment within the terminal repeat region.

Authors:  Yuri Yakushko; Christian Hackmann; Thomas Günther; Jessica Rückert; Marc Henke; Lars Koste; Khaled Alkharsah; Jens Bohne; Adam Grundhoff; Thomas F Schulz; Cornelia Henke-Gendo
Journal:  J Virol       Date:  2011-02-09       Impact factor: 5.103

5.  MAFFT multiple sequence alignment software version 7: improvements in performance and usability.

Authors:  Kazutaka Katoh; Daron M Standley
Journal:  Mol Biol Evol       Date:  2013-01-16       Impact factor: 16.240

Review 6.  Inhibition of IL-6 for the treatment of inflammatory diseases.

Authors:  Norihiro Nishimoto; Tadamitsu Kishimoto
Journal:  Curr Opin Pharmacol       Date:  2004-08       Impact factor: 5.547

7.  Vironome of Kaposi sarcoma associated herpesvirus-inflammatory cytokine syndrome in an AIDS patient reveals co-infection of human herpesvirus 8 and human herpesvirus 6A.

Authors:  Kristen M Tamburro; Dongmei Yang; Jessica Poisson; Yuri Fedoriw; Debasmita Roy; Amy Lucas; Sang-Hoon Sin; Nadia Malouf; Vincent Moylan; Blossom Damania; Stephan Moll; Charles van der Horst; Dirk P Dittmer
Journal:  Virology       Date:  2012-08-24       Impact factor: 3.616

Review 8.  Treatment of Kaposi Sarcoma Herpesvirus-Associated Multicentric Castleman Disease.

Authors:  Kathryn Lurain; Robert Yarchoan; Thomas S Uldrick
Journal:  Hematol Oncol Clin North Am       Date:  2018-02       Impact factor: 3.722

9.  Faster quantitative real-time PCR protocols may lose sensitivity and show increased variability.

Authors:  Chelsey Hilscher; Wolfgang Vahrson; Dirk P Dittmer
Journal:  Nucleic Acids Res       Date:  2005-11-27       Impact factor: 16.971

10.  Genome-Wide Sequence Analysis of Kaposi Sarcoma-Associated Herpesvirus Shows Diversification Driven by Recombination.

Authors:  Neneh Sallah; Anne L Palser; Simon J Watson; Nazzarena Labo; Gershim Asiki; Vickie Marshall; Robert Newton; Denise Whitby; Paul Kellam; Inês Barroso
Journal:  J Infect Dis       Date:  2018-10-20       Impact factor: 5.226

View more
  9 in total

1.  Interleukin-1 Receptor-Associated Kinase (IRAK) Signaling in Kaposi Sarcoma-Associated Herpesvirus-Induced Primary Effusion Lymphoma.

Authors:  Jedediah Seltzer; Razia Moorad; Jason M Schifano; Justin T Landis; Dirk P Dittmer
Journal:  J Virol       Date:  2020-05-04       Impact factor: 5.103

Review 2.  Activation and Evasion of Innate Immunity by Gammaherpesviruses.

Authors:  Philip T Lange; Maria C White; Blossom Damania
Journal:  J Mol Biol       Date:  2021-08-23       Impact factor: 5.469

3.  Whole-genome sequencing of Kaposi sarcoma-associated herpesvirus (KSHV/HHV8) reveals evidence for two African lineages.

Authors:  Razia Moorad; Angelica Juarez; Justin T Landis; Linda J Pluta; Megan Perkins; Avery Cheves; Dirk P Dittmer
Journal:  Virology       Date:  2022-02-02       Impact factor: 3.616

Review 4.  Castleman disease.

Authors:  Antonino Carbone; Margaret Borok; Blossom Damania; Annunziata Gloghini; Mark N Polizzotto; Raj K Jayanthan; David C Fajgenbaum; Mark Bower
Journal:  Nat Rev Dis Primers       Date:  2021-11-25       Impact factor: 65.038

5.  vRhyme enables binning of viral genomes from metagenomes.

Authors:  Kristopher Kieft; Alyssa Adams; Rauf Salamzade; Lindsay Kalan; Karthik Anantharaman
Journal:  Nucleic Acids Res       Date:  2022-08-12       Impact factor: 19.160

6.  Pulmonary Kaposi Sarcoma without Respiratory Symptoms and Skin Lesions in an HIV-Naïve Patient: A Case Report and Literature Review.

Authors:  Cristina Micali; Ylenia Russotto; Alessio Facciolà; Andrea Marino; Benedetto Maurizio Celesia; Eugenia Pistarà; Grazia Caci; Giuseppe Nunnari; Giovanni Francesco Pellicanò; Emmanuele Venanzi Rullo
Journal:  Infect Dis Rep       Date:  2022-03-25

7.  Intra-host changes in Kaposi sarcoma-associated herpesvirus genomes in Ugandan adults with Kaposi sarcoma.

Authors:  Jan Clement Santiago; Jason D Goldman; Hong Zhao; Alec P Pankow; Fred Okuku; Michael W Schmitt; Lennie H Chen; C Alexander Hill; Corey Casper; Warren T Phipps; James I Mullins
Journal:  PLoS Pathog       Date:  2021-01-19       Impact factor: 6.823

Review 8.  KSHV: Immune Modulation and Immunotherapy.

Authors:  Grant Broussard; Blossom Damania
Journal:  Front Immunol       Date:  2020-02-07       Impact factor: 7.561

Review 9.  Cytokine-Targeted Therapeutics for KSHV-Associated Disease.

Authors:  Nedaa Alomari; Jennifer Totonchy
Journal:  Viruses       Date:  2020-09-28       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.